Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Project title: NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024<br/>Offer reference number CM/PHS/24/5707 Period of framework: 1 August 2024 to 31 July 2025. with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months<br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England The Procurement relates to the supply of medical retinal vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Abbvie Ltd | 08004972 | ~£1,597,500,000 estimated from lot values | 1 lot Lot 1 | LOBBYIST Policy Connect Limited (15 quarters) Portland PR Limited (3 quarters) WA Communications Ltd (3 quarters) Incisive Health Ltd (1 quarter) Political Lobbying & Media Relations Limited (1 quarter) |
| Alimera Sciences | 08018355 | ~£1,597,500,000 estimated from lot values | 1 lot Lot 1 | - |
| Bayer plc | - | ~£1,597,500,000 estimated from lot values | 1 lot Lot 1 | - |
| BIOGEN IDEC LIMITED | 01497267 | ~£1,597,500,000 estimated from lot values | 1 lot Lot 1 | LOBBYIST Portland PR Limited (2 quarters) Hawthorn Advisors Limited (1 quarter) |
| NOVARTIS PHARMACEUTICALS UK LIMITED | 00119006 | ~£1,597,500,000 estimated from lot values | 1 lot Lot 1 | DONOR£3K across 2 donations To: Mr Nicholas Palmer LOBBYIST M&F Health (7 quarters) Sovereign Strategy Limited (1 quarter) MP LINK Mr David Lammy— Employment and earnings |
| Orion Pharma (UK) Ltd | 02281057 | ~£1,597,500,000 estimated from lot values | 1 lot Lot 1 | LOBBYIST Rud Pedersen UK Limited (5 quarters) |
| ROCHE PRODUCTS LIMITED | 00100674 | ~£1,597,500,000 estimated from lot values | 1 lot Lot 1 | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| TEVA UK LIMITED | 00302461 | ~£1,597,500,000 estimated from lot values | 1 lot Lot 1 | - |
| Thornton and Ross Ltd | 00185947 | ~£1,597,500,000 estimated from lot values | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 81 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Aug 2024 – Jul 2025 | £1,597,500,000 £9 initial term | 9 | Bayer plc TEVA UK LIMITED ROCHE PRODUCTS LIMITED Thornton and Ross Ltd Abbvie Ltd BIOGEN IDEC LIMITED NOVARTIS PHARMACEUTICALS UK LIMITED Alimera Sciences Orion Pharma (UK) Ltd | active |
Weightings from the notice.
Government spending data: These suppliers have received £413,082,859 in 4,211 payments (over £25k) from Manchester University NHS Foundation Trust, Department of Health and Social Care, NHS England, Guy's and St Thomas' NHS FT, Royal Cornwall Hospitals NHS Trust and 17 more public bodies (2010-07-22 to 2026-03-31).
Published by the buyer on this notice. Check the original notice — details change and are not updated here.